학술논문

SARS-CoV-2 NSP5 antagonizes MHC II expression by subverting histone deacetylase 2.
Document Type
Article
Source
Journal of Cell Science. May2024, Vol. 137 Issue 10, p1-18. 18p.
Subject
*GENE expression
*TRANSCRIPTION factors
*SARS-CoV-2
*MAJOR histocompatibility complex
*T cell receptors
*ANTIGEN presentation
Language
ISSN
0021-9533
Abstract
SARS-CoV-2 interferes with antigen presentation by downregulating major histocompatibility complex (MHC) II on antigen-presenting cells, but the mechanism mediating this process is unelucidated. Herein, analysis of protein and gene expression in human antigen-presenting cells reveals that MHC II is downregulated by the SARS-CoV-2 main protease, NSP5. This suppression of MHC II expression occurs via decreased expression of the MHC II regulatory protein CIITA. CIITA downregulation is independent of the proteolytic activity of NSP5, and rather, NSP5 delivers HDAC2 to the transcription factor IRF3 at an IRF-binding site within the CIITA promoter. Here, HDAC2 deacetylates and inactivates the CIITA promoter. This loss of CIITA expression prevents further expression of MHC II, with this suppression alleviated by ectopic expression of CIITA or knockdown of HDAC2. These results identify a mechanism by which SARS-CoV-2 limits MHC II expression, thereby delaying or weakening the subsequent adaptive immune response. [ABSTRACT FROM AUTHOR]